Nahed S. Alharthi, Maher S. Alwethaynani, Abdulfattah Y. Alhazmi, Abdullah S. Alawam, Faez Falah Alshehri, Faisal Alotaibi, Zia ur Rehman, Faris F. Aba Alkhayl, Maha M. Al-Bazi, Farhan R. Khan
{"title":"将天然小分子作为程序性死亡配体 1 抑制剂用于癌症免疫疗法的硅学评估：一种计算方法","authors":"Nahed S. Alharthi, Maher S. Alwethaynani, Abdulfattah Y. Alhazmi, Abdullah S. Alawam, Faez Falah Alshehri, Faisal Alotaibi, Zia ur Rehman, Faris F. Aba Alkhayl, Maha M. Al-Bazi, Farhan R. Khan","doi":"10.1080/07391102.2024.2317980","DOIUrl":null,"url":null,"abstract":"Programmed cell death ligand 1 (PD-L1) is a crucial target for cancer therapy. Here, an in silico study investigates PD-L1 to inhibit its interaction with PD1, thereby promoting an immune response ...","PeriodicalId":15085,"journal":{"name":"Journal of Biomolecular Structure and Dynamics","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In silico assessment of a natural small molecule as an inhibitor of programmed death ligand 1 for cancer immunotherapy: a computational approach\",\"authors\":\"Nahed S. Alharthi, Maher S. Alwethaynani, Abdulfattah Y. Alhazmi, Abdullah S. Alawam, Faez Falah Alshehri, Faisal Alotaibi, Zia ur Rehman, Faris F. Aba Alkhayl, Maha M. Al-Bazi, Farhan R. Khan\",\"doi\":\"10.1080/07391102.2024.2317980\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Programmed cell death ligand 1 (PD-L1) is a crucial target for cancer therapy. Here, an in silico study investigates PD-L1 to inhibit its interaction with PD1, thereby promoting an immune response ...\",\"PeriodicalId\":15085,\"journal\":{\"name\":\"Journal of Biomolecular Structure and Dynamics\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Biomolecular Structure and Dynamics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/07391102.2024.2317980\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biomolecular Structure and Dynamics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/07391102.2024.2317980","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
In silico assessment of a natural small molecule as an inhibitor of programmed death ligand 1 for cancer immunotherapy: a computational approach
Programmed cell death ligand 1 (PD-L1) is a crucial target for cancer therapy. Here, an in silico study investigates PD-L1 to inhibit its interaction with PD1, thereby promoting an immune response ...
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
